Nothing Special   »   [go: up one dir, main page]

NO903291L - PURE-INHIBITIVE AMINOOLIGO HYDROXYDE DERIVATIVES. - Google Patents

PURE-INHIBITIVE AMINOOLIGO HYDROXYDE DERIVATIVES.

Info

Publication number
NO903291L
NO903291L NO90903291A NO903291A NO903291L NO 903291 L NO903291 L NO 903291L NO 90903291 A NO90903291 A NO 90903291A NO 903291 A NO903291 A NO 903291A NO 903291 L NO903291 L NO 903291L
Authority
NO
Norway
Prior art keywords
aminooligo
hydroxyde
inhibitive
derivatives
pure
Prior art date
Application number
NO90903291A
Other languages
Norwegian (no)
Other versions
NO903291D0 (en
Inventor
Heinz-Werner Kleemann
Hansjoerg Urbach
Adalbert Wagner
Dieter Ruppert
Wolfgang Linz
Werner Kramer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3924506A external-priority patent/DE3924506A1/en
Priority claimed from DE19893932817 external-priority patent/DE3932817A1/en
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO903291D0 publication Critical patent/NO903291D0/en
Publication of NO903291L publication Critical patent/NO903291L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Peptides Or Proteins (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Footwear And Its Accessory, Manufacturing Method And Apparatuses (AREA)
  • Solid Fuels And Fuel-Associated Substances (AREA)
  • Saccharide Compounds (AREA)

Abstract

The present invention relates to compounds of the formula I <IMAGE> in which A, R<2>, R<3>, R<4> and n are defined as indicated in the description, to processes for the preparation thereof, to the use thereof as medicines and to pharmaceutical compositions containing these.
NO90903291A 1989-07-25 1990-07-24 PURE-INHIBITIVE AMINOOLIGO HYDROXYDE DERIVATIVES. NO903291L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3924506A DE3924506A1 (en) 1989-07-25 1989-07-25 New poly:hydroxy:amide derivs.
DE19893932817 DE3932817A1 (en) 1989-09-30 1989-09-30 New poly:hydroxy:amide derivs.

Publications (2)

Publication Number Publication Date
NO903291D0 NO903291D0 (en) 1990-07-24
NO903291L true NO903291L (en) 1991-01-28

Family

ID=25883333

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90903291A NO903291L (en) 1989-07-25 1990-07-24 PURE-INHIBITIVE AMINOOLIGO HYDROXYDE DERIVATIVES.

Country Status (20)

Country Link
EP (1) EP0410278B1 (en)
JP (1) JPH0366652A (en)
KR (1) KR910002776A (en)
CN (1) CN1049164A (en)
AT (1) ATE100463T1 (en)
AU (1) AU639246B2 (en)
CA (1) CA2021822A1 (en)
CS (1) CS368890A3 (en)
DE (1) DE59004292D1 (en)
DK (1) DK0410278T3 (en)
ES (1) ES2062214T3 (en)
FI (1) FI903701A0 (en)
HU (1) HU205140B (en)
IE (1) IE902686A1 (en)
IL (1) IL95166A0 (en)
MA (1) MA21913A1 (en)
NO (1) NO903291L (en)
NZ (1) NZ234608A (en)
PL (1) PL286188A1 (en)
PT (1) PT94798A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW209870B (en) * 1990-01-18 1993-07-21 Pfizer
IE68045B1 (en) * 1990-05-11 1996-05-15 Abbott Lab Renin inhibitors
AU8740991A (en) * 1990-08-24 1992-03-17 Upjohn Company, The Peptides containing amino-polyols as transition-state mimics
EP0483403A1 (en) * 1990-10-31 1992-05-06 Hoechst Aktiengesellschaft Derivatives of amino acids as inhibitors of renin, methods for their preparation, medicaments containing them and their use
AU2001246864B2 (en) * 2000-04-10 2006-07-27 Protein Express Co., Ltd. Hypotensors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK34086A (en) * 1985-01-23 1986-07-24 Abbott Lab PEPTIDYLAMINODIOLS
NZ218937A (en) * 1986-01-16 1990-03-27 Abbott Lab Functionalised peptidyl aminodiols and -triols as renin inhibitors and pharmaceutical compositions
US4863905A (en) * 1987-02-04 1989-09-05 Warner-Lambert Company Renin inhibitors II

Also Published As

Publication number Publication date
AU639246B2 (en) 1993-07-22
CS368890A3 (en) 1992-02-19
CA2021822A1 (en) 1991-01-26
PT94798A (en) 1991-03-20
ES2062214T3 (en) 1994-12-16
DK0410278T3 (en) 1994-05-24
FI903701A0 (en) 1990-07-23
EP0410278B1 (en) 1994-01-19
JPH0366652A (en) 1991-03-22
HU904582D0 (en) 1990-12-28
DE59004292D1 (en) 1994-03-03
CN1049164A (en) 1991-02-13
EP0410278A1 (en) 1991-01-30
NO903291D0 (en) 1990-07-24
HUT55033A (en) 1991-04-29
IL95166A0 (en) 1991-06-10
MA21913A1 (en) 1991-04-01
KR910002776A (en) 1991-02-26
PL286188A1 (en) 1991-04-22
ATE100463T1 (en) 1994-02-15
HU205140B (en) 1992-03-30
IE902686A1 (en) 1991-02-27
NZ234608A (en) 1991-12-23
AU5971990A (en) 1991-01-31

Similar Documents

Publication Publication Date Title
IL101819A0 (en) Amidinophenylalanine derivatives,a process for the preparation thereof,use thereof and agents containing these as anticoagulants
ES2074846T3 (en) NEW NAFTIL-ETIL-UREAS AND NAFTIL-ETIL-TIOUREAS, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
IL90912A0 (en) Condensed heterocyclic compounds,their manufacture and pharmaceutical compositions containing them
ES2123039T3 (en) NEW 3- (HYDROXY-BENCILIDENIL) -INDOLIN-2-ONAS, ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
GR3018212T3 (en) Naphtylalkylamines, process for their preparation and pharmaceutical compositions containing them.
GR3029406T3 (en) Pyridothiadiazines, processes for their preparation and pharmaceutical compositions containing them.
DE69312984D1 (en) Substituted aminophosphonate derivatives, processes for their preparation and pharmaceutical compositions containing them
ES2111871T3 (en) NEW AMINO ACID DERIVATIVES, THEIR PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
HUT46664A (en) Process for producing new dihydropyridineamide derivatives and pharmaceutical compositions comprising these compounds
DK0564358T3 (en) 3-Aminochroman Spiro Derivatives, Methods of Preparation thereof and Pharmaceutical Compositions Containing Such
NO903291L (en) PURE-INHIBITIVE AMINOOLIGO HYDROXYDE DERIVATIVES.
ZA933455B (en) Thiochroman compounds, processes for the preparation thereof and pharmaceutical compositions containing them
ES2062313T3 (en) 13-BROMO- AND 13,14-DIBROMO-ERGOLINAS, TO ITS PREPARATION AND TO ITS USE IN MEDICINES.
ES2076054T3 (en) NEW AMINO-ALKYL-CHROME, ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
SE9203824L (en) BENSOFURANYLIMIDAZOLE DERIVATIVES, PROCEDURES FOR PREPARING THEREOF AND THERAPEUTIC COMPOSITIONS CONTAINING THEM
DK0552631T3 (en) Alpha-aryl-alpha-hydroxy-beta-imidazolinyl propionsyreamider
ES2103553T3 (en) NEW CYCLLOALKYL- (B) -INDOLES, THEIR PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
ZA933942B (en) Pyrrolothienopyrazine compounds, processes for the preparation thereof and pharmaceutical compositions containing them